A pair of new studies finds no significant benefit of the antiviral drug nirmatrelvir-ritonavir (Paxlovid) in alleviating the ...

Antiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving long COVID symptoms, according to a ...

Cytochrome P450 (CYP) proteins are responsible for breaking down more than 80% of all Food and Drug Administration (FDA)-approved drugs, reducing their effectiveness. However, how to prevent CYPs from ...

Clinical trials moved quickly, and by the end of the year we had the very first oral COVID antiviral, called nirmatrelvir. The pace of the drug’s development was astonishing. Despite using the ...

The suit – filed in a Massachusetts district court – claims that Paxlovid (nirmatrelvir and ritonavir) infringes its 11,358,953 patent which covers "compounds and pharmaceutically acceptable ...

Paxlovid is a prescription-only oral antiviral medication containing nirmatrelvir and ritonavir. It treats mild to moderate COVID-19 symptoms and is particularly effective if you are unvaccinated.